Related Experiment Videos
Summary
Scalp hypothermia can reduce chemotherapy-induced hair loss, improving patient treatment adherence. However, caution is advised for certain cancers, as it may allow scalp metastasis recurrence, as seen in a mycosis fungoides case.
Area of Science:
- Oncology
- Dermatology
Background:
- Scalp hypothermia is used to mitigate temporary epilation from cytotoxic chemotherapy.
- This method has enhanced patient compliance with cancer treatment regimens.
Observation:
- Scalp hypothermia is contraindicated in tumors with high scalp metastasis prevalence, such as leukemia and lymphoma.
- A patient with mycosis fungoides used a cooling cap during chemotherapy.
Findings:
- The patient experienced cutaneous disease recurrence on the scalp.
- No other evidence of mycosis fungoides was detected elsewhere in the body.
Implications:
- Caution is warranted when using scalp hypothermia in patients with tumors that manifest cutaneous stem cell nests.
- Reducing scalp drug delivery may risk localized recurrence in susceptible malignancies.